Biomedicine & Pharmacotherapy (May 2023)

Role of sirtuins in metabolic disease-related renal injury

  • Huan-Huan Chen,
  • Yi-Xiao Zhang,
  • Jia-Le Lv,
  • Yu-Yang Liu,
  • Jing-Yi Guo,
  • Lu Zhao,
  • Yu-Xin Nan,
  • Qi-Jun Wu,
  • Yu-Hong Zhao

Journal volume & issue
Vol. 161
p. 114417

Abstract

Read online

Poor control of metabolic diseases induces kidney injury, resulting in microalbuminuria, renal insufficiency and, ultimately, chronic kidney disease. The potential pathogenetic mechanisms of renal injury caused by metabolic diseases remain unclear. Tubular cells and podocytes of the kidney show high expression of histone deacetylases known as sirtuins (SIRT1–7). Available evidence has shown that SIRTs participate in pathogenic processes of renal disorders caused by metabolic diseases. The present review addresses the regulatory roles of SIRTs and their implications for the initiation and development of kidney damage due to metabolic diseases. SIRTs are commonly dysregulated in renal disorders induced by metabolic diseases such as hypertensive nephropathy and diabetic nephropathy. This dysregulation is associated with disease progression. Previous literature has also suggested that abnormal expression of SIRTs affects cellular biology, such as oxidative stress, metabolism, inflammation, and apoptosis of renal cells, resulting in the promotion of invasive diseases. This literature reviews the research progress made in understanding the roles of dysregulated SIRTs in the pathogenesis of metabolic disease-related kidney disorders and describes the potential of SIRTs serve as biomarkers for early screening and diagnosis of these diseases and as therapeutic targets for their treatment.

Keywords